Literatur
Ghaneh P, Palmer DH, Cicconi S et al (2020) ESPAC-5F: Four- arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. J Clin Oncol 38(2020):abstr 4505
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Roth und M. Schneider geben an, dass kein Interessenkonflikt besteht.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Roth, S., Schneider, M. Neoadjuvante Behandlungskonzepte bei Borderline-resektablem Pankreaskarzinom. Chirurgie 93, 995–996 (2022). https://doi.org/10.1007/s00104-022-01729-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-022-01729-1